Go Pro
→ Your book attached (From Profits Run) (Ad)tc pixel Free SCYX Stock Alerts

SCYNEXIS (SCYX) Financials

SCYNEXIS logo
$4.27 -0.21 (-4.69%)
Closing price 07/17/2026 04:00 PM Eastern
Extended Trading
$4.28 +0.02 (+0.35%)
As of 07/17/2026 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare
Annual Income Statements for SCYNEXIS

Annual Income Statements for SCYNEXIS

This table shows SCYNEXIS's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 -33 -30 -25 -12 -54 -55 -33 -63 67 -21 -8.61
Consolidated Net Income / (Loss)		 -33 -30 -25 -12 -54 -55 -33 -63 67 -21 -8.61
Net Income / (Loss) Continuing Operations		 -28 -30 -25 -12 -54 -55 -33 -63 67 -21 -8.61
Total Pre-Tax Income 		-28 -30 -25 -19 -54 -58 -36 -68 67 -21 -8.61
Total Operating Income		 -28 -28 -26 -30 -49 -51 -61 -86 73 -37 -16
Total Gross Profit		 0.26 0.26 0.26 0.26 0.12 0.00 13 5.09 125 3.75 21
Total Revenue		 0.26 0.26 0.26 0.26 0.12 0.00 13 5.09 140 3.75 21
Operating Revenue		 0.26 0.26 0.26 0.26 0.12 0.00 13 5.09 140 3.75 21
Total Cost of Revenue		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 16 0.00 0.00
Operating Cost of Revenue		 - - - - - - - - 16 - 0.00
Total Operating Expenses		 29 28 27 30 49 51 74 91 52 41 37
Selling, General & Admin Expense		 12 8.00 8.25 8.68 11 15 50 63 21 14 14
Research & Development Expense		 16 20 18 22 38 37 24 27 31 26 22
Total Other Income / (Expense), net		 0.01 -2.17 1.26 11 -4.79 -7.18 25 18 -5.49 16 7.47
Interest Expense		 -0.01 0.45 1.86 2.05 3.20 4.15 6.69 6.79 6.12 2.55 0.49
Interest & Investment Income		 0.00 0.19 0.39 0.97 0.81 0.19 0.02 1.42 3.95 4.29 2.18
Other Income / (Expense), net		 0.00 -1.91 2.73 12 -2.39 -3.23 32 24 -3.32 14 5.77
Income Tax Expense		 0.00 - 0.00 -6.74 0.00 -3.15 -3.09 -4.70 0.14 0.15 0.00
Basic Earnings per Share		 ($2.68) - - - - - ($1.25) ($1.47) $1.40 ($0.44) ($0.17)
Weighted Average Basic Shares Outstanding		 12.16M 19.04M 26.75M 43.88M 5.61M 10.72M 26.38M 42.61M 47.85M 48.51M 49.93M
Diluted Earnings per Share		 ($2.68) - - - - - ($1.25) ($1.47) $1.39 ($0.44) ($0.17)
Weighted Average Diluted Shares Outstanding		 12.16M 19.04M 26.75M 43.88M 5.61M 10.72M 26.38M 42.61M 48.39M 48.51M 49.93M
Weighted Average Basic & Diluted Shares Outstanding		 13.91M 19.04M 26.75M 43.88M 5.61M 10.72M 26.38M 33.32M 37.75M 38.98M 44.66M

Quarterly Income Statements for SCYNEXIS

This table shows SCYNEXIS's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders		 -1.76 -20 0.41 -14 -2.81 -4.43 -5.39 -6.89 -8.59 12 -21
Consolidated Net Income / (Loss)		 -1.76 -20 0.41 -14 -2.81 -4.43 -5.39 -6.89 -8.59 12 -21
Net Income / (Loss) Continuing Operations		 -1.76 -20 0.41 -14 -2.81 -4.43 -5.39 -6.89 -8.59 12 -21
Total Pre-Tax Income 		-1.76 -19 0.94 -14 -3.20 -4.42 0.00 -6.89 -8.59 12 0.00
Total Operating Income		 -10 -23 -9.51 -9.24 -10 -8.05 -8.61 -9.56 -8.41 11 -17
Total Gross Profit		 1.76 -9.40 1.37 0.74 0.66 0.98 0.26 1.36 0.33 19 0.00
Total Revenue		 1.76 5.80 1.37 0.74 0.66 0.98 0.26 1.36 0.33 19 0.00
Operating Revenue		 1.76 5.80 1.37 0.74 0.66 0.98 0.26 1.36 0.33 19 0.00
Total Cost of Revenue		 0.00 15 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00
Total Operating Expenses		 12 14 11 9.97 11 9.03 8.87 11 8.74 8.14 17
Selling, General & Admin Expense		 5.01 3.59 3.67 3.17 2.91 4.72 3.73 3.78 3.29 3.60 4.59
Research & Development Expense		 6.47 11 7.21 6.81 8.07 4.31 5.14 7.14 5.45 4.55 12
Other Operating Expenses / (Income)		 0.38 - 0.00 - - - 0.00 - 0.00 - 0.00
Total Other Income / (Expense), net		 8.34 3.62 10 -5.22 7.12 3.63 3.22 2.68 -0.19 1.76 -4.36
Interest Expense		 0.57 0.60 0.61 0.62 0.65 0.68 0.49 0.00 0.00 - 0.00
Interest & Investment Income		 1.26 1.37 1.28 1.13 1.02 0.86 0.78 0.51 0.45 0.44 0.54
Other Income / (Expense), net		 7.65 2.85 9.78 -5.73 6.75 3.45 2.93 2.17 -0.64 1.32 -4.90
Income Tax Expense		 0.00 0.14 0.53 0.00 -0.40 0.02 0.00 0.00 0.00 - 0.00
Basic Earnings per Share		 ($0.04) ($0.41) $0.01 ($0.30) ($0.06) ($0.09) ($0.11) ($0.14) ($0.17) $0.25 ($0.42)
Weighted Average Basic Shares Outstanding		 47.89M 47.85M 48.25M 48.51M 48.62M 48.51M 49.44M 49.75M 49.90M 49.93M 50.96M
Diluted Earnings per Share		 ($0.04) ($0.32) $0.01 ($0.30) ($0.06) ($0.09) ($0.11) ($0.14) ($0.17) $0.25 ($0.42)
Weighted Average Diluted Shares Outstanding		 47.89M 48.39M 48.57M 48.51M 48.62M 48.51M 49.44M 49.75M 49.90M 49.93M 50.96M
Weighted Average Basic & Diluted Shares Outstanding		 37.21M 37.75M 37.78M 37.86M 37.95M 38.98M 39.02M 41.92M 41.97M 44.66M 79.44M

Annual Cash Flow Statements for SCYNEXIS

This table details how cash moves in and out of SCYNEXIS's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents		 15 -11 -24 0.30 30 51 11 -59 -11 -18 4.85
Net Cash From Operating Activities		 -25 -29 -25 -28 -38 -49 -55 -80 60 -24 -5.28
Net Cash From Continuing Operating Activities		 -25 -29 -25 -28 -38 -49 -55 -80 60 -24 -5.28
Net Income / (Loss) Continuing Operations		 -33 -30 -25 -12 -54 -55 -33 -63 67 -21 -8.61
Consolidated Net Income / (Loss)		 -33 -30 -25 -12 -54 -55 -33 -63 67 -21 -8.61
Depreciation Expense		 0.45 0.03 0.04 0.05 0.11 0.11 0.38 0.61 0.58 0.00 0.00
Amortization Expense		 0.00 0.42 0.40 0.43 1.17 1.20 1.30 1.28 1.65 0.39 -0.16
Non-Cash Adjustments To Reconcile Net Income		 3.68 3.23 -0.94 -9.93 5.96 7.74 -27 -20 -0.30 1.17 7.67
Changes in Operating Assets and Liabilities, net		 3.95 -3.03 1.01 -6.41 8.35 -3.22 3.15 0.76 -8.82 -4.28 -4.18
Net Cash From Investing Activities		 1.59 -22 -9.62 -0.80 26 6.47 -1.17 -27 -35 6.15 24
Net Cash From Continuing Investing Activities		 1.59 -22 -9.62 -0.80 26 6.47 -1.17 -27 -35 6.15 24
Acquisitions		 - - - - - 0.00 -1.17 -0.01 0.00 0.00 0.00
Purchase of Investments		 -0.30 -36 -78 -85 -40 -14 0.00 -27 -85 -36 -19
Sale and/or Maturity of Investments		 0.00 13 69 85 66 21 - 0.00 51 43 43
Net Cash From Financing Activities		 38 40 9.99 29 42 94 67 49 -37 -0.14 -14
Net Cash From Continuing Financing Activities		 38 40 9.99 29 42 94 67 49 -37 -0.14 -14
Repayment of Debt		 0.00 -0.60 - 0.00 -17 -0.49 -1.25 -0.03 -36 0.00 -14
Repurchase of Common Equity		 -3.81 -2.00 -0.33 - - -0.21 0.00 0.00 -0.12 -0.20 -0.23
Issuance of Common Equity		 42 28 10 32 46 91 39 47 0.04 0.06 0.06
Other Financing Activities, net		 0.00 - - -2.27 -2.86 -5.88 -0.21 -3.64 -0.26 0.00 0.00
Cash Interest Paid		 0.00 0.35 1.46 1.62 0.85 1.09 2.26 5.19 3.25 0.84 0.42
Cash Interest Received		 0.00 0.48 0.51 0.99 0.90 0.19 0.02 1.11 3.52 3.30 2.08

Quarterly Cash Flow Statements for SCYNEXIS

This table details how cash moves in and out of SCYNEXIS's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents		 -14 -10 1.43 -9.49 2.74 -13 -9.11 3.78 3.72 6.46 15
Net Cash From Operating Activities		 12 -7.74 -4.01 -11 0.77 -9.91 -7.47 -7.50 -8.72 18 -8.10
Net Cash From Continuing Operating Activities		 12 -7.74 -4.01 -11 0.77 -9.91 -7.47 -7.50 -8.72 18 -8.10
Net Income / (Loss) Continuing Operations		 -1.76 -20 0.41 -14 -2.81 -4.43 -5.39 -6.89 -8.59 12 -21
Consolidated Net Income / (Loss)		 -1.76 -20 0.41 -14 -2.81 -4.43 -5.39 -6.89 -8.59 12 -21
Amortization Expense		 -0.44 -0.26 0.15 0.05 -0.04 0.22 0.11 -0.12 -0.10 -0.06 -0.04
Non-Cash Adjustments To Reconcile Net Income		 16 12 -6.65 6.28 4.30 -2.76 -1.50 -1.54 1.25 9.46 15
Changes in Operating Assets and Liabilities, net		 -1.16 -0.19 2.08 -2.74 -0.69 -2.93 -0.69 1.05 -1.28 -3.25 -1.44
Net Cash From Investing Activities		 -26 -2.15 5.45 1.37 1.94 -2.62 12 11 12 -12 -0.53
Net Cash From Continuing Investing Activities		 -26 -2.15 5.45 1.37 1.94 -2.62 12 11 12 -12 -0.53
Purchase of Investments		 -46 -12 -2.51 -8.21 -17 -8.43 0.00 - - -19 -3.28
Sale and/or Maturity of Investments		 20 10 7.96 9.58 19 5.82 12 11 12 7.08 2.75
Net Cash From Financing Activities		 0.03 -0.14 -0.02 - 0.03 -0.16 -14 - 0.03 -0.12 24
Net Cash From Continuing Financing Activities		 0.03 -0.14 -0.02 - 0.03 -0.16 -14 - 0.03 -0.12 24
Repayment of Debt		 - - 0.00 - - - -14 - - - 0.00
Repurchase of Common Equity		 - -0.14 - - - - -0.11 - - - 0.00
Issuance of Common Equity		 0.03 - 0.03 - 0.03 - 0.03 - 0.03 0.00 24
Cash Interest Paid		 0.42 - 0.42 - 0.42 - 0.42 - - - 0.00
Cash Interest Received		 1.21 0.88 1.04 0.68 0.90 0.67 0.63 0.60 0.41 0.45 0.32

Annual Balance Sheets for SCYNEXIS

This table presents SCYNEXIS's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets		 49 60 46 53 57 103 120 88 128 91 59
Total Current Assets		 48 59 45 51 52 98 109 79 102 72 40
Cash & Equivalents		 47 36 11 11 42 93 104 46 34 16 21
Restricted Cash		 - - 0.00 0.06 - - 0.00 0.06 0.38 0.44 0.08
Short-Term Investments		 0.00 23 32 33 6.49 - 0.00 28 40 43 19
Prepaid Expenses		 1.45 0.74 1.07 7.25 3.99 5.17 3.57 2.50 5.55 2.18 0.26
Other Current Assets		 - - - - - - - 0.00 22 10 0.00
Plant, Property, & Equipment, net		 0.00 0.00 0.00 0.52 0.41 0.30 0.00 0.00 0.00 0.00 0.00
Total Noncurrent Assets		 0.84 0.47 0.89 1.19 4.35 4.03 10 8.75 26 18 19
Noncurrent Note & Lease Receivables		 - - - 0.00 3.19 3.00 2.80 2.59 2.36 2.09 1.76
Other Noncurrent Operating Assets		 0.84 0.47 0.89 1.19 1.16 1.03 6.60 5.75 24 16 17
Total Liabilities & Shareholders' Equity		 49 60 46 53 57 103 120 88 128 91 59
Total Liabilities		 7.32 25 24 22 44 80 79 85 55 36 9.65
Total Current Liabilities		 6.66 3.72 10 5.88 11 26 14 18 16 24 5.73
Short-Term Debt		 - 0.00 4.35 0.00 - 0.05 0.07 0.28 0.34 0.41 0.48
Accounts Payable		 0.62 2.19 3.83 3.65 7.18 4.64 7.85 5.94 7.15 4.57 2.23
Accrued Expenses		 5.79 1.27 1.71 2.10 3.80 4.14 5.70 5.63 7.50 3.79 2.79
Current Deferred Revenue		 0.26 0.26 0.26 0.12 - - - 0.00 1.19 1.64 0.24
Other Current Liabilities		 - - - - 0.04 18 0.00 5.77 0.13 14 0.00
Total Noncurrent Liabilities		 0.66 21 14 16 33 53 65 67 39 11 3.92
Noncurrent Deferred Revenue		 0.66 0.40 0.12 - - - - 0.00 2.73 1.29 0.00
Other Noncurrent Operating Liabilities		 0.00 6.60 3.87 0.99 33 53 36 33 36 10 3.92
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 42 35 21 31 13 23 41 3.23 73 55 49
Total Preferred & Common Equity		 42 35 21 31 13 23 41 3.23 73 55 49
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 42 35 21 31 13 23 41 3.23 73 55 49
Common Stock		 192 215 227 249 284 349 401 426 428 432 435
Retained Earnings		 -150 -180 -205 -218 -271 -327 -359 -422 -355 -377 -385

Quarterly Balance Sheets for SCYNEXIS

This table presents SCYNEXIS's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026
Total Assets		 149 118 108 99 68 61 51 78
Total Current Assets		 129 102 95 80 52 56 49 63
Cash & Equivalents		 44 35 26 29 6.94 11 15 37
Restricted Cash		 0.38 0.38 0.38 0.44 0.44 0.14 0.08 0.08
Short-Term Investments		 44 45 47 40 34 34 23 23
Prepaid Expenses		 3.17 1.58 1.42 1.54 1.45 1.58 0.69 0.92
Other Current Assets		 22 19 20 9.66 9.73 10 10 2.43
Plant, Property, & Equipment, net		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Noncurrent Assets		 20 17 13 19 16 4.20 2.38 15
Other Noncurrent Operating Assets		 17 14 11 16 14 2.26 0.53 15
Total Liabilities & Shareholders' Equity		 149 118 108 99 68 61 51 78
Total Liabilities		 57 44 47 41 17 16 15 36
Total Current Liabilities		 17 27 25 26 8.96 11 8.47 16
Accounts Payable		 3.49 8.92 5.35 4.96 4.26 6.17 3.47 5.63
Accrued Expenses		 9.54 4.60 5.50 5.51 2.63 2.48 2.77 1.53
Current Deferred Revenue		 2.44 1.08 1.23 1.64 1.64 1.77 1.77 0.24
Other Current Liabilities		 1.00 12 0.00 13 - 0.00 0.00 8.50
Total Noncurrent Liabilities		 40 17 22 15 8.43 5.36 6.17 20
Noncurrent Deferred Revenue		 1.65 2.11 1.82 1.29 1.29 0.52 0.81 0.00
Other Noncurrent Operating Liabilities		 38 15 20 13 7.13 4.85 5.37 20
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 92 74 60 59 51 44 36 41
Total Preferred & Common Equity		 92 74 60 59 51 44 36 41
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 92 74 60 59 51 44 36 41
Common Stock		 428 429 430 431 432 433 434 448
Retained Earnings		 -336 -355 -369 -372 -382 -389 -397 -406

Annual Metrics And Ratios for SCYNEXIS

This table displays calculated financial ratios and metrics derived from SCYNEXIS's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding		 13,905,599.00 23,990,603.00 28,558,957.00 47,971,673.00 58,370,895.00 10,940,119.00 23,950,121.00 32,656,992.00 37,207,799.00 37,948,991.00 41,965,058.00
DEI Adjusted Shares Outstanding		 1,390,560.00 2,399,060.00 2,855,896.00 4,797,167.00 5,837,089.00 10,940,119.00 23,950,121.00 32,656,992.00 37,207,799.00 37,948,991.00 41,965,058.00
DEI Earnings Per Adjusted Shares Outstanding		 -23.46 -12.50 -8.77 -2.60 -9.20 -5.04 -1.37 -1.92 1.80 -0.56 -0.21
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 -79.54% 0.00% 0.00% 0.00% -52.92% -100.00% 0.00% -61.32% 2,652.72% -97.33% 449.95%
EBITDA Growth		 -979.80% -4.95% 20.94% 23.82% -183.69% -6.06% 47.97% -118.24% 218.81% -131.42% 53.47%
EBIT Growth		 -519.38% -4.85% 20.63% 23.20% -183.23% -5.97% 46.13% -112.14% 211.61% -132.98% 54.97%
NOPAT Growth		 -93.55% 1.88% 5.38% -13.92% -63.16% -4.55% -18.94% -40.96% 220.81% -135.83% 56.69%
Net Income Growth		 -670.50% 8.07% 16.44% 50.25% -330.78% -2.75% 40.44% -91.11% 206.74% -131.75% 59.56%
EPS Growth		 0.37% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -17.60% 194.56% -131.65% 61.36%
Operating Cash Flow Growth		 -159.13% -19.59% 16.34% -15.34% -34.59% -29.47% -10.55% -46.41% 175.31% -139.91% 78.00%
Free Cash Flow Firm Growth		 -23.34% 16.25% -34.12% -53.74% 110.90% -132.42% -7,078.12% 25.02% 165.16% -160.48% -8.98%
Invested Capital Growth		 -62.82% -88.94% 17.70% 126.75% -1,795.42% -97.73% 51.00% -3.60% 95.96% -195.21% 329.31%
Revenue Q/Q Growth		 107.60% 0.39% 0.00% 0.00% -34.95% 0.00% 4.75% 22.26% 3.14% -56.26% 602.63%
EBITDA Q/Q Growth		 -18.68% 4.19% -24.14% 13.50% -22.88% -104.56% 32.90% 19.30% -9.44% 41.71% 60.67%
EBIT Q/Q Growth		 -16.77% 2.78% -21.48% 12.99% -22.85% -99.09% 31.14% 19.12% -9.17% 40.56% 61.46%
NOPAT Q/Q Growth		 -16.77% 9.01% -6.17% -5.75% -12.20% -2.45% -12.92% -0.22% -1.00% 28.80% 53.58%
Net Income Q/Q Growth		 -19.45% 14.14% -19.80% 43.32% -43.95% -104.90% 29.07% 19.08% -7.14% 41.58% 65.97%
EPS Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 28.16% 9.82% 2.96% 34.33% 66.67%
Operating Cash Flow Q/Q Growth		 -21.01% 4.64% -2.52% -3.28% -24.09% -6.73% -19.62% 3.29% 33.43% -9.95% 84.27%
Free Cash Flow Firm Q/Q Growth		 -61.39% -5.90% 10.63% -62.35% 122.04% 97.04% -229.60% -19.22% 53.95% -3.99% 24.56%
Invested Capital Q/Q Growth		 -32.67% 13.81% -32.89% 131.28% -61.95% -251.31% -1.46% 19.90% -137.27% 58.91% 974.26%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 100.00% 100.00% 100.00% 100.00% 100.00% 0.00% 100.00% 100.00% 88.85% 100.00% 100.00%
EBITDA Margin		 -10,856.81% -11,393.77% -9,007.78% -6,862.26% -41,347.93% 0.00% -209.74% -1,183.48% 51.08% -600.32% -50.79%
Operating Margin		 -11,030.74% -10,823.74% -10,241.25% -11,666.54% -40,430.58% 0.00% -462.19% -1,684.48% 51.85% -990.84% -78.03%
EBIT Margin		 -11,030.74% -11,565.37% -9,179.38% -7,049.42% -42,407.44% 0.00% -222.52% -1,220.53% 49.49% -610.62% -50.00%
Profit (Net Income) Margin		 -12,693.77% -11,668.87% -9,750.97% -4,851.36% -44,388.43% 0.00% -249.68% -1,233.73% 47.84% -568.29% -41.79%
Tax Burden Percent		 115.12% 100.00% 100.00% 64.92% 100.00% 94.60% 91.41% 93.04% 99.79% 100.71% 100.00%
Interest Burden Percent		 99.96% 100.89% 106.23% 106.00% 104.67% 107.28% 122.75% 108.65% 96.87% 92.41% 83.57%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.21% 0.00% 0.00%
Return on Invested Capital (ROIC)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -409.38%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -414.72%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 392.90%
Return on Equity (ROE)		 -86.56% -78.13% -89.14% -47.38% -243.47% -309.57% -102.68% -282.34% 175.97% -33.25% -16.48%
Cash Return on Invested Capital (CROIC)		 0.00% 0.00% 0.00% -1,475.61% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -259.04%
Operating Return on Assets (OROA)		 -63.75% -54.51% -44.66% -36.59% -93.02% 0.00% -26.34% -59.85% 64.15% -20.88% -13.76%
Return on Assets (ROA)		 -73.36% -54.99% -47.44% -25.18% -97.37% 0.00% -29.56% -60.50% 62.01% -19.44% -11.50%
Return on Common Equity (ROCE)		 -86.56% -78.13% -89.14% -47.38% -243.47% -309.57% -102.68% -282.34% 175.97% -33.25% -16.48%
Return on Equity Simple (ROE_SIMPLE)		 -77.77% -86.13% -117.05% -39.93% -416.52% -242.49% -79.66% -1,942.75% 91.88% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 -20 -19 -18 -21 -34 -36 -43 -60 73 -26 -11
NOPAT Margin		 -7,721.52% -7,576.61% -7,168.87% -8,166.58% -28,301.41% 0.00% -323.53% -1,179.14% 51.75% -693.59% -54.62%
Net Nonoperating Expense Percent (NNEP)		 -30.60% -23.03% -18.04% 29.19% -50.20% -27.41% 11.53% -4.85% -9.67% 7.02% 5.34%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - - - 98.93% -46.83% -22.57%
Cost of Revenue to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 11.15% 0.00% 0.00%
SG&A Expenses to Revenue		 4,733.85% 3,112.06% 3,210.51% 3,377.43% 8,800.00% 0.00% 379.21% 1,236.71% 14.93% 385.96% 69.88%
R&D to Revenue		 6,396.89% 7,811.67% 7,130.74% 8,389.11% 31,730.58% 0.00% 180.60% 535.44% 22.07% 704.89% 108.15%
Operating Expenses to Revenue		 11,130.74% 10,923.74% 10,341.25% 11,766.54% 40,530.58% 0.00% 562.19% 1,784.48% 37.00% 1,090.84% 178.03%
Earnings before Interest and Taxes (EBIT)		 -28 -30 -24 -18 -51 -54 -29 -62 69 -23 -10
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -28 -29 -23 -18 -50 -53 -28 -60 72 -22 -10
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 2.06 2.20 3.09 0.74 4.12 3.68 3.54 15.76 1.14 0.83 0.54
Price to Tangible Book Value (P/TBV)		 2.06 2.20 3.09 0.74 4.12 3.68 3.63 18.03 1.14 0.83 0.54
Price to Revenue (P/Rev)		 336.01 297.78 257.81 89.91 438.99 0.00 11.10 10.01 0.59 12.26 1.29
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1.24 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 80.80% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)		 153.19 125.28 144.03 0.00 38.87 0.00 5.35 2.37 0.06 0.00 0.00
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.12 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.12 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.12 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.14 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 1.40 0.00 0.00 0.00 0.22 0.00 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.00 0.41 0.68 0.48 0.00 0.00 0.70 10.73 0.00 0.01 0.01
Long-Term Debt to Equity		 0.00 0.41 0.48 0.48 0.00 0.00 0.70 10.64 0.00 0.00 0.00
Financial Leverage		 -1.11 -1.19 -1.31 -1.11 -1.76 -3.97 -2.63 -2.57 -1.49 -1.04 -0.95
Leverage Ratio		 1.18 1.42 1.88 1.88 2.50 4.48 3.47 4.67 2.84 1.71 1.43
Compound Leverage Factor		 1.18 1.43 2.00 1.99 2.62 4.81 4.26 5.07 2.75 1.58 1.20
Debt to Total Capital		 0.00% 29.04% 40.63% 32.57% 0.00% 0.23% 41.12% 91.47% 0.46% 0.73% 0.97%
Short-Term Debt to Total Capital		 0.00% 0.00% 12.06% 0.00% 0.00% 0.23% 0.10% 0.74% 0.46% 0.73% 0.97%
Long-Term Debt to Total Capital		 0.00% 29.04% 28.57% 32.57% 0.00% 0.00% 41.02% 90.73% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 100.00% 70.96% 59.37% 67.43% 100.00% 99.77% 58.88% 8.53% 99.54% 99.27% 99.03%
Debt to EBITDA		 0.00 -0.49 -0.63 -0.86 0.00 0.00 -1.04 -0.58 0.00 -0.02 -0.05
Net Debt to EBITDA		 0.00 1.51 1.26 1.65 0.00 1.75 2.74 0.65 -1.04 2.64 3.79
Long-Term Debt to EBITDA		 0.00 -0.49 -0.45 -0.86 0.00 0.00 -1.04 -0.57 0.00 0.00 0.00
Debt to NOPAT		 0.00 -0.73 -0.80 -0.72 0.00 0.00 -0.68 -0.58 0.00 -0.02 -0.04
Net Debt to NOPAT		 0.00 2.28 1.59 1.39 0.00 2.60 1.78 0.65 -1.03 2.28 3.52
Long-Term Debt to NOPAT		 0.00 -0.73 -0.56 -0.72 0.00 0.00 -0.68 -0.57 0.00 0.00 0.00
Altman Z-Score		 1.93 -2.90 -5.42 -5.19 -8.02 -4.74 -2.82 -7.81 0.70 -5.20 -7.01
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 7.27 15.96 4.43 8.76 4.76 3.72 8.03 4.49 6.26 3.00 7.04
Quick Ratio		 7.05 15.76 4.33 7.51 4.40 3.52 7.74 4.29 4.56 2.46 6.98
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -18 -15 -20 -31 3.37 -1.09 -78 -59 38 -23 -25
Operating Cash Flow to CapEx		 0.00% 0.00% -1,227,800.00% -5,012.92% 0.00% -1,233,850.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow to Firm to Interest Expense		 0.00 -33.24 -10.84 -15.05 1.05 -0.26 -11.72 -8.66 6.26 -9.07 -52.06
Operating Cash Flow to Interest Expense		 0.00 -65.08 -13.24 -13.79 -11.90 -11.90 -8.16 -11.77 9.82 -9.40 -10.89
Operating Cash Flow Less CapEx to Interest Expense		 0.00 -64.04 -13.24 -14.06 -11.90 -11.90 -8.16 -11.77 9.82 -9.40 -10.89
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.01 0.00 0.00 0.01 0.00 0.00 0.12 0.05 1.30 0.03 0.28
Accounts Receivable Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 3.44 0.00 0.00 0.00
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 0.00 0.00 0.00 0.99 0.26 0.00 0.00 0.00 0.00 0.00 0.00
Accounts Payable Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 2.39 0.00 0.00
Days Sales Outstanding (DSO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 106.18 0.00 0.00 0.00
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 152.85 0.00 0.00
Cash Conversion Cycle (CCC)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 106.18 -152.85 0.00 0.00
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 -5.04 -9.52 -7.83 2.10 -36 -70 -34 -36 -1.44 -4.25 9.75
Invested Capital Turnover		 -0.06 -0.04 -0.03 -0.09 -0.01 0.00 -0.25 -0.15 -7.56 -1.32 7.50
Increase / (Decrease) in Invested Capital		 -1.94 -4.48 1.68 9.93 -38 -35 36 -1.24 34 -2.81 14
Enterprise Value (EV)		 39 32 37 -6.02 4.70 -9.30 70 12 8.57 -13 -13
Market Capitalization		 86 77 66 23 53 84 146 51 83 46 27
Book Value per Share		 $3.02 $1.45 $0.75 $0.65 $0.22 $2.08 $1.72 $0.10 $1.96 $1.45 $1.18
Tangible Book Value per Share		 $3.02 $1.45 $0.75 $0.65 $0.22 $2.08 $1.68 $0.09 $1.96 $1.45 $1.18
Total Capital		 42 49 36 46 13 23 70 38 73 55 50
Total Debt		 0.00 14 15 15 0.00 0.05 29 35 0.34 0.41 0.48
Total Long-Term Debt		 0.00 14 10 15 0.00 0.00 29 34 0.00 0.00 0.00
Net Debt		 -47 -44 -29 -29 -48 -93 -76 -39 -74 -59 -40
Capital Expenditures (CapEx)		 -1.96 -0.47 0.00 0.57 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -5.21 -2.98 -4.73 1.37 -7.03 -21 -8.65 -12 11 -11 -4.99
Debt-free Net Working Capital (DFNWC)		 42 56 39 46 41 72 96 62 86 48 35
Net Working Capital (NWC)		 42 56 35 46 41 72 96 61 86 48 35
Net Nonoperating Expense (NNE)		 13 11 6.64 -8.52 19 19 -9.72 2.78 5.48 -4.69 -2.64
Net Nonoperating Obligations (NNO)		 -47 -44 -29 -29 -48 -93 -76 -39 -74 -59 -40
Total Depreciation and Amortization (D&A)		 0.45 0.44 0.44 0.48 1.28 1.31 1.68 1.89 2.23 0.39 -0.16
Debt-free, Cash-free Net Working Capital to Revenue		 -2,028.02% -1,157.98% -1,839.69% 534.63% -5,806.61% 0.00% -65.74% -232.43% 8.14% -300.21% -24.21%
Debt-free Net Working Capital to Revenue		 16,254.09% 21,638.13% 15,239.30% 17,737.74% 34,204.96% 0.00% 728.03% 1,212.43% 61.48% 1,294.42% 170.49%
Net Working Capital to Revenue		 16,254.09% 21,638.13% 13,547.08% 17,737.74% 34,204.96% 0.00% 727.50% 1,206.89% 61.23% 1,283.56% 168.15%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($26.80) ($15.80) $0.00 $0.00 $0.00 $0.00 $0.00 ($1.47) $1.40 ($0.44) ($0.17)
Adjusted Weighted Average Basic Shares Outstanding		 1.22M 1.90M 4.68M 5.01M 9.74M 20.62M 28.94M 42.61M 47.85M 48.51M 49.93M
Adjusted Diluted Earnings per Share		 ($26.80) ($15.80) $0.00 $0.00 $0.00 $0.00 $0.00 ($1.47) $1.39 ($0.44) ($0.17)
Adjusted Weighted Average Diluted Shares Outstanding		 1.22M 1.90M 4.68M 5.01M 9.74M 20.62M 28.94M 42.61M 48.39M 48.51M 49.93M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 1.39M 2.55M 2.67M 4.39M 5.61M 10.72M 26.38M 33.32M 37.75M 38.98M 44.66M
Normalized Net Operating Profit after Tax (NOPAT)		 -20 -19 -18 -21 -34 -36 -43 -60 73 -26 -11
Normalized NOPAT Margin		 -7,721.52% -7,576.61% -7,168.87% -8,166.58% -28,301.41% 0.00% -323.53% -1,179.14% 51.75% -693.59% -54.62%
Pre Tax Income Margin		 -11,026.46% -11,668.87% -9,750.97% -7,472.37% -44,388.43% 0.00% -273.14% -1,326.05% 47.94% -564.26% -41.79%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 -65.90 -12.72 -8.82 -16.03 -13.11 -4.38 -9.16 11.32 -8.96 -21.24
NOPAT to Interest Expense		 0.00 -43.17 -9.93 -10.22 -10.69 -8.63 -6.37 -8.84 11.84 -10.17 -23.20
EBIT Less CapEx to Interest Expense		 0.00 -64.86 -12.72 -9.10 -16.03 -13.11 -4.38 -9.16 11.32 -8.96 -21.24
NOPAT Less CapEx to Interest Expense		 0.00 -42.13 -9.93 -10.49 -10.69 -8.63 -6.37 -8.84 11.84 -10.17 -23.20
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 -11.66% -6.66% -1.33% 0.00% 0.00% -0.38% 0.01% 0.00% 0.17% -0.92% -2.63%

Quarterly Metrics And Ratios for SCYNEXIS

This table displays calculated financial ratios and metrics derived from SCYNEXIS's official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding		 37,175,665.00 37,207,799.00 37,753,481.00 37,779,796.00 37,856,463.00 37,948,991.00 38,981,064.00 39,020,274.00 41,924,941.00 41,965,058.00 44,663,832.00
DEI Adjusted Shares Outstanding		 37,175,665.00 37,207,799.00 37,753,481.00 37,779,796.00 37,856,463.00 37,948,991.00 38,981,064.00 39,020,274.00 41,924,941.00 41,965,058.00 44,663,832.00
DEI Earnings Per Adjusted Shares Outstanding		 -0.05 -0.53 0.01 -0.38 -0.07 -0.12 -0.14 -0.18 -0.20 0.29 -0.48
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 13.10% 280.32% 21.50% -99.44% -62.52% -83.14% -81.28% 85.33% -49.39% 1,808.50% -100.00%
EBITDA Growth		 90.16% -57.98% 101.28% -111.72% -31.43% 78.46% -1,438.70% 49.65% -153.62% 368.35% -292.80%
EBIT Growth		 91.36% -53.03% 100.82% -112.00% -45.79% 77.23% -2,220.15% 50.60% -153.43% 356.81% -284.27%
NOPAT Growth		 53.68% -2.60% 44.52% -105.55% -2.20% 65.09% -45.29% -3.51% 18.56% 286.32% -96.74%
Net Income Growth		 94.06% -35.74% 101.21% -111.83% -59.82% 77.37% -1,411.68% 52.38% -205.95% 376.52% -295.08%
EPS Growth		 93.55% 11.11% 101.41% -112.20% -50.00% 71.88% -1,200.00% 53.33% -183.33% 377.78% -281.82%
Operating Cash Flow Growth		 155.18% 66.08% 78.82% -114.60% -93.84% -28.08% -86.30% 30.99% -1,240.39% 285.74% -8.52%
Free Cash Flow Firm Growth		 -1,086.67% -247.35% -340.65% -98.86% 112.60% 94.39% 53.79% -916.34% -316.37% -23.77% 172.81%
Invested Capital Growth		 108.68% 95.96% 87.64% -98.06% -367.73% -195.21% 260.88% -106.25% 89.22% 329.31% -281.91%
Revenue Q/Q Growth		 -98.66% 229.13% -76.31% -46.39% -10.33% 48.03% -73.70% 430.74% -75.51% 5,482.63% -100.00%
EBITDA Q/Q Growth		 -102.16% -641.63% 102.04% -3,685.82% 75.83% -21.55% -27.09% -34.85% -21.74% 228.61% -286.03%
EBIT Q/Q Growth		 -101.96% -725.65% 101.33% -5,685.82% 76.16% -28.97% -23.44% -30.15% -22.31% 230.69% -284.71%
NOPAT Q/Q Growth		 -106.07% -128.41% 74.31% -55.87% -11.72% 21.98% -6.93% -11.05% 12.09% 278.50% -212.91%
Net Income Q/Q Growth		 -101.44% -1,014.74% 102.10% -3,617.76% 80.58% -57.87% -21.61% -27.71% -24.78% 242.68% -273.76%
EPS Q/Q Growth		 -101.63% -700.00% 103.13% -3,100.00% 80.00% -50.00% -22.22% -27.27% -21.43% 247.06% -268.00%
Operating Cash Flow Q/Q Growth		 -83.31% -162.28% 48.20% -171.03% 107.04% -1,395.03% 24.65% -0.40% -16.40% 310.92% -144.02%
Free Cash Flow Firm Q/Q Growth		 -179.16% 9.17% 5.01% 101.67% 771.93% -140.45% -682.37% 70.42% -131.10% 76.86% 560.21%
Invested Capital Q/Q Growth		 -47.86% -137.27% -327.99% 102.34% -7,284.03% 58.91% 333.24% -100.09% -12,288.89% 974.26% -285.02%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 100.00% -162.22% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 0.00%
EBITDA Margin		 -155.76% -350.98% 30.30% -2,026.77% -546.21% -448.52% -2,166.93% -550.59% -2,737.43% 63.06% 0.00%
Operating Margin		 -573.42% -397.95% -692.50% -1,255.03% -1,563.64% -824.16% -3,350.19% -700.95% -2,516.47% 56.32% 0.00%
EBIT Margin		 -139.01% -348.72% 19.52% -2,033.97% -540.76% -471.14% -2,210.89% -542.16% -2,708.08% 63.40% 0.00%
Profit (Net Income) Margin		 -99.77% -337.92% 29.93% -1,964.40% -425.45% -453.74% -2,097.67% -504.77% -2,572.16% 65.74% 0.00%
Tax Burden Percent		 100.00% 100.71% 43.63% 100.00% 87.67% 100.34% 0.00% 100.00% 100.00% 100.00% 0.00%
Interest Burden Percent		 71.77% 96.22% 351.49% 96.58% 89.75% 95.98% 0.00% 93.10% 94.98% 103.70% 0.00%
Effective Tax Rate		 0.00% 0.00% 56.37% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 0.00% 0.00% 0.00% -2,247.99% 0.00% 0.00% -3,287.69% -23,682.87% 0.00% 422.16% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 0.00% 0.00% -2,237.03% 0.00% 0.00% -3,288.74% -23,682.50% 0.00% 418.61% 0.00%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 0.00% 0.00% 2,126.92% 0.00% 0.00% 3,189.74% 23,652.02% 0.00% -396.58% 0.00%
Return on Equity (ROE)		 132.23% 175.97% 458.59% -121.07% -48.42% -33.25% -97.95% -30.85% -53.29% 25.58% -53.39%
Cash Return on Invested Capital (CROIC)		 644.02% 0.00% 0.00% -769.52% 0.00% 0.00% -417.86% 0.00% 0.00% -259.04% 0.00%
Operating Return on Assets (OROA)		 -144.82% -452.04% 29.07% -149.70% -37.41% -16.11% -62.47% -20.97% -105.79% 17.45% 0.00%
Return on Assets (ROA)		 -103.94% -438.04% 44.58% -144.58% -29.44% -15.52% -59.27% -19.52% -100.48% 18.10% 0.00%
Return on Common Equity (ROCE)		 132.23% 175.97% 458.59% -121.07% -48.42% -33.25% -97.95% -30.85% -53.29% 25.58% -53.39%
Return on Equity Simple (ROE_SIMPLE)		 78.48% 0.00% 136.74% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 -7.07 -16 -4.15 -6.47 -7.22 -5.64 -6.03 -6.69 -5.88 11 -12
NOPAT Margin		 -401.40% -278.56% -302.14% -878.52% -1,094.55% -576.91% -2,345.14% -490.67% -1,761.53% 56.32% 0.00%
Net Nonoperating Expense Percent (NNEP)		 7.09% -6.07% 9.10% -10.95% 5.63% 1.80% 1.05% -0.37% -5.09% 3.55% -18.89%
Return On Investment Capital (ROIC_SIMPLE)		 - -22.03% -5.57% -8.79% -12.26% -10.16% -11.83% -14.90% -15.95% 21.06% -28.71%
Cost of Revenue to Revenue		 0.00% 262.22% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
SG&A Expenses to Revenue		 284.72% 61.97% 267.23% 430.16% 440.45% 482.70% 1,449.81% 277.42% 984.13% 19.30% 0.00%
R&D to Revenue		 367.18% 182.66% 525.27% 924.86% 1,223.18% 441.45% 2,000.39% 523.53% 1,632.34% 24.38% 0.00%
Operating Expenses to Revenue		 673.42% 235.73% 792.50% 1,355.03% 1,663.64% 924.16% 3,450.19% 800.95% 2,616.47% 43.68% 0.00%
Earnings before Interest and Taxes (EBIT)		 -2.45 -20 0.27 -15 -3.57 -4.60 -5.68 -7.40 -9.05 12 -22
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -2.74 -20 0.42 -15 -3.61 -4.38 -5.57 -7.51 -9.14 12 -22
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 0.92 1.14 0.75 1.25 0.96 0.83 0.73 0.59 0.89 0.54 0.99
Price to Tangible Book Value (P/TBV)		 0.92 1.14 0.75 1.25 0.96 0.83 0.73 0.59 0.89 0.54 0.99
Price to Revenue (P/Rev)		 0.62 0.59 0.40 7.82 6.59 12.26 14.11 8.08 11.01 1.29 2.01
Price to Earnings (P/E)		 1.17 1.24 0.55 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 85.18% 80.80% 182.58% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.00 0.00 0.00 106.23 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)		 0.00 0.06 0.00 1.58 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.12 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.12 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.12 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.14 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.22 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.00 0.00 0.00 0.22 0.01 0.01 0.01 0.01 0.01 0.01 0.00
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage		 -1.37 -1.49 -2.27 -0.95 -1.04 -1.04 -0.97 -1.00 -1.12 -0.95 -1.09
Leverage Ratio		 2.39 2.84 4.27 1.71 1.64 1.71 1.49 1.61 1.58 1.43 1.58
Compound Leverage Factor		 1.71 2.73 15.00 1.65 1.48 1.64 0.00 1.50 1.50 1.49 0.00
Debt to Total Capital		 0.35% 0.46% 0.48% 17.88% 0.66% 0.73% 0.83% 0.99% 1.26% 0.97% 0.00%
Short-Term Debt to Total Capital		 0.35% 0.46% 0.48% 17.88% 0.66% 0.73% 0.83% 0.99% 1.26% 0.97% 0.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 99.65% 99.54% 99.52% 82.12% 99.34% 99.27% 99.17% 99.01% 98.75% 99.03% 100.00%
Debt to EBITDA		 0.00 0.00 0.00 -0.35 -0.01 -0.02 -0.01 -0.02 -0.02 -0.05 0.00
Net Debt to EBITDA		 -1.11 -1.04 -0.77 1.59 1.79 2.64 1.43 2.11 1.41 3.79 0.00
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT		 0.00 0.00 0.00 -0.36 -0.01 -0.02 -0.02 -0.02 -0.02 -0.04 0.00
Net Debt to NOPAT		 -1.20 -1.03 -1.09 1.66 1.89 2.28 1.60 1.74 1.55 3.52 0.00
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score		 -0.50 -1.60 -1.50 -3.44 -3.79 -4.53 -6.06 -7.44 -9.15 -5.77 -6.60
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 7.66 6.26 3.72 3.75 3.13 3.00 5.83 5.20 5.75 7.04 3.94
Quick Ratio		 5.38 4.56 2.93 2.89 2.68 2.46 4.53 4.12 4.48 6.98 3.73
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -55 -50 -48 0.80 6.99 -2.83 -22 -6.54 -15 -3.50 16
Operating Cash Flow to CapEx		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow to Firm to Interest Expense		 -96.92 -83.51 -78.93 1.30 10.68 -4.18 -45.58 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 21.71 -12.83 -6.61 -17.57 1.17 -14.66 -15.39 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 21.71 -12.83 -6.61 -17.57 1.17 -14.66 -15.39 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 1.04 1.30 1.49 0.07 0.07 0.03 0.03 0.04 0.04 0.28 0.28
Accounts Receivable Turnover		 57.35 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Inventory Turnover		 0.04 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Accounts Payable Turnover		 0.05 2.39 2.11 3.47 3.60 0.00 0.00 0.00 0.00 0.00 0.00
Days Sales Outstanding (DSO)		 6.36 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Inventory Outstanding (DIO)		 8,995.57 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 7,059.90 152.85 173.38 105.26 101.41 0.00 0.00 0.00 0.00 0.00 0.00
Cash Conversion Cycle (CCC)		 1,942.03 -152.85 -173.38 -105.26 -101.41 0.00 0.00 0.00 0.00 0.00 0.00
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 3.86 -1.44 -6.16 0.14 -10 -4.25 9.92 -0.01 -1.12 9.75 -18
Invested Capital Turnover		 -6.69 -7.56 -5.01 2.56 -2.64 -1.32 1.40 48.27 -0.51 7.50 -5.01
Increase / (Decrease) in Invested Capital		 48 34 44 -7.27 -14 -2.81 16 -0.15 9.23 14 -28
Enterprise Value (EV)		 -3.37 8.57 -25 15 -12 -13 -3.50 -18 -5.26 -13 -18
Market Capitalization		 85 83 55 76 56 46 37 26 32 27 41
Book Value per Share		 $2.47 $1.96 $1.96 $1.60 $1.55 $1.45 $1.30 $1.14 $0.87 $1.18 $0.92
Tangible Book Value per Share		 $2.47 $1.96 $1.96 $1.60 $1.55 $1.45 $1.30 $1.14 $0.87 $1.18 $0.92
Total Capital		 92 73 74 74 59 55 51 45 37 50 41
Total Debt		 0.33 0.34 0.36 13 0.39 0.41 0.43 0.44 0.46 0.48 0.00
Total Long-Term Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt		 -88 -74 -80 -60 -69 -59 -41 -44 -38 -40 -59
Capital Expenditures (CapEx)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 24 11 -5.94 9.08 -14 -11 2.65 1.16 2.68 -4.99 -13
Debt-free Net Working Capital (DFNWC)		 112 86 75 83 55 48 44 46 41 35 47
Net Working Capital (NWC)		 112 86 74 69 55 48 43 46 40 35 47
Net Nonoperating Expense (NNE)		 -5.31 3.44 -4.56 7.99 -4.42 -1.20 -0.64 0.19 2.71 -1.76 9.44
Net Nonoperating Obligations (NNO)		 -88 -74 -80 -60 -69 -59 -41 -44 -38 -40 -59
Total Depreciation and Amortization (D&A)		 -0.30 -0.13 0.15 0.05 -0.04 0.22 0.11 -0.12 -0.10 -0.06 -0.04
Debt-free, Cash-free Net Working Capital to Revenue		 17.46% 8.14% -4.23% 93.97% -164.97% -300.21% 100.65% 35.57% 91.41% -24.21% -61.70%
Debt-free Net Working Capital to Revenue		 82.56% 61.48% 53.20% 853.52% 643.70% 1,294.42% 1,661.18% 1,414.33% 1,387.72% 170.49% 230.00%
Net Working Capital to Revenue		 82.32% 61.23% 52.94% 717.41% 639.16% 1,283.56% 1,645.02% 1,400.71% 1,371.93% 168.15% 230.00%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($0.04) ($0.41) $0.01 ($0.30) ($0.06) ($0.09) ($0.11) ($0.14) ($0.17) $0.25 ($0.42)
Adjusted Weighted Average Basic Shares Outstanding		 47.89M 47.85M 48.25M 48.51M 48.62M 48.51M 49.44M 49.75M 49.90M 49.93M 50.96M
Adjusted Diluted Earnings per Share		 ($0.04) ($0.32) $0.01 ($0.30) ($0.06) ($0.09) ($0.11) ($0.14) ($0.17) $0.25 ($0.42)
Adjusted Weighted Average Diluted Shares Outstanding		 47.89M 48.39M 48.57M 48.51M 48.62M 48.51M 49.44M 49.75M 49.90M 49.93M 50.96M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 37.21M 37.75M 37.78M 37.86M 37.95M 38.98M 39.02M 41.92M 41.97M 44.66M 79.44M
Normalized Net Operating Profit after Tax (NOPAT)		 -7.07 -16 -6.66 -6.47 -7.22 -5.64 -6.03 -6.69 -5.88 7.35 -12
Normalized NOPAT Margin		 -401.40% -278.56% -484.75% -878.52% -1,094.55% -576.91% -2,345.14% -490.67% -1,761.53% 39.43% 0.00%
Pre Tax Income Margin		 -99.77% -335.54% 68.61% -1,964.40% -485.30% -452.20% 0.00% -504.77% -2,572.16% 65.74% 0.00%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 -4.28 -33.52 0.44 -24.22 -5.46 -6.81 -11.72 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 -12.36 -26.78 -6.85 -10.46 -11.05 -8.34 -12.43 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 -4.28 -33.52 0.44 -24.22 -5.46 -6.81 -11.72 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 -12.36 -26.78 -6.85 -10.46 -11.05 -8.34 -12.43 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 -0.02% 0.17% 0.00% 0.00% 0.00% -0.92% 0.00% 0.00% 0.00% -2.63% -0.47%

Financials Breakdown Chart

Key Financial Trends

SCYNEXIS entered 2026 with a much stronger balance sheet than it had a year ago, but the latest quarter also showed a return to heavy operating losses and cash burn. The company ended Q1 2026 with $36.7 million in cash and equivalents and $22.6 million in short-term investments, giving it a sizable liquidity cushion. However, the quarter included no revenue and a net loss of $21.3 million, which highlights how dependent the business remains on non-operating income and financing activity.

Compared with the prior year, the underlying trend is mixed. Revenue was highly volatile in 2025 and disappeared entirely in Q1 2026 after a strong Q4 2025 quarter. Operating expenses also remained elevated, with R&D at $12.4 million and SG&A at $4.6 million in Q1 2026, leading to a -$16.9 million operating loss. On the positive side, the company’s cash balance improved sharply from $14.8 million in Q3 2025 and $11.0 million in Q2 2025, helped by a large equity issuance.

The key takeaway for investors is that SCYNEXIS currently has enough liquidity to keep operating, but the core business is still not producing consistent revenue or profits. The near-term story depends on whether the company can rebuild recurring sales and reduce reliance on financing and investment gains.

  • Cash and equivalents rose to $36.7 million in Q1 2026, up sharply from $14.8 million in Q3 2025.
  • Total current assets reached $62.7 million, while total liabilities were only $36.3 million, leaving a stronger liquidity position.
  • The company generated a large $24.0 million inflow from issuance of common equity in Q1 2026, which boosted the cash balance.
  • Short-term debt was modest at $463,000 in Q1 2026, suggesting limited near-term balance sheet leverage.
  • Interest and investment income helped support results, with $535,000 of interest/investment income and $316,000 of interest received in Q1 2026.
  • The company’s cash position has been rebuilt over several quarters, but much of the improvement came from financing and portfolio activity rather than operating performance.
  • Revenue was highly inconsistent: $18.6 million in Q4 2025, $334,000 in Q3 2025, $1.4 million in Q2 2025, and $0 in Q1 2026.
  • Q1 2026 net loss was $21.3 million, a sharp deterioration from the $12.3 million profit in Q4 2025.
  • Operating cash flow was -$8.1 million in Q1 2026, showing the business is still burning cash from operations.
  • Non-operating income swung sharply negative in Q1 2026, with other income/expense of -$4.9 million, adding pressure to the bottom line.

Looking at the broader 4-year trend, SCYNEXIS has moved from periods of large cash reserves and occasional profitable quarters to a more volatile, highly diluted equity story. Shares outstanding have trended higher over time, and retained earnings remain deeply negative at -$406.4 million in Q1 2026, reflecting the cumulative history of losses.

Overall, the latest quarter suggests improved solvency, but weak operating quality. Investors should watch for sustainable revenue generation, tighter operating expenses, and whether the company can avoid repeated reliance on dilution to fund the business.

07/18/26 11:25 AM ETAI Generated. May Contain Errors.

SCYNEXIS Financials - Frequently Asked Questions

According to the most recent income statement we have on file, SCYNEXIS's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

SCYNEXIS's net income appears to be on a downward trend, with a most recent value of -$8.61 million in 2025, falling from -$32.62 million in 2015. The previous period was -$21.29 million in 2024. View SCYNEXIS's forecast to see where analysts expect SCYNEXIS to go next.

SCYNEXIS's total operating income in 2025 was -$16.07 million, based on the following breakdown:
  • Total Gross Profit: $20.60 million
  • Total Operating Expenses: $36.68 million

Over the last 10 years, SCYNEXIS's total revenue changed from $257 thousand in 2015 to $20.60 million in 2025, a change of 7,916.0%.

SCYNEXIS's total liabilities were at $9.65 million at the end of 2025, a 72.9% decrease from 2024, and a 31.8% increase since 2015.

In the past 10 years, SCYNEXIS's cash and equivalents has ranged from $11.44 million in 2018 to $104.48 million in 2021, and is currently $21.26 million as of their latest financial filing in 2025.

Over the last 10 years, SCYNEXIS's book value per share changed from 3.02 in 2015 to 1.18 in 2025, a change of -61.0%.


Related Companies

Financial statements for NASDAQ:SCYX last updated on 7/16/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
The only metrics you should watch as a day trader.
Day traders and swing traders don't need the same metrics - and using the wrong ones costs you edge. After 40 ...
The TradingPub | Sponsoredtc pixel
Your withdrawal order could cost you in taxes
If you have $2M or more saved, the 4% rule points to roughly $92,000 a year - but it's a single-variable answe...
SmartAsset | Sponsoredtc pixel
#1 Question to Ask Your Bank Today
Elon Musk's new banking platform is paying up to 15 times the national average interest rate while insuring de...
InvestorPlace | Sponsoredtc pixel
Buy this stock tomorrow
Marc Chaikin, founder of Chaikin Analytics, is flagging a little-known company that just secured a partnership...
Chaikin Analytics | Sponsoredtc pixel
SPCX Warning - and Worst News for Stocks in 50 Years
Goldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...
TradeSmith | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
URGENT Dollar Reset Warning for Monday
A 50-year U.S.-Saudi arrangement established under Henry Kissinger - one credited with anchoring the dollar in...
Golden Portfolio | Sponsoredtc pixel